Observational Study of Patients Using NovoMix® 30 or Levemir® for Treatment of Type 1 or Type 2 Diabetes
Status:
Completed
Trial end date:
2008-09-01
Target enrollment:
Participant gender:
Summary
This trial is conducted in Europe.
The aim of this observational study is to evaluate the glycaemic control in patients with
type 1 or 2 diabetes using NovoMix® 30 or Levemir® under normal clinical practice conditions.